Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
13.83
+0.09 (0.66%)
Jun 4, 2026, 12:36 PM EDT - Market open

Avalo Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel Nicolaus
Stifel Nicolaus
Buy
Maintains
$36$39
BuyMaintains$36$39+182.00%May 15, 2026
Wedbush
Wedbush
Buy
Reiterates
$40$34
BuyReiterates$40$34+145.84%May 14, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$39$45
BuyMaintains$39$45+225.38%May 14, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$40$35
BuyReiterates$40$35+153.07%May 14, 2026
BTIG
BTIG
Buy
Maintains
$58
BuyMaintains$58+319.38%May 14, 2026
Citizens JMP
Citizens JMP
Buy
Maintains
$62$55
BuyMaintains$62$55+297.69%May 14, 2026
Piper Sandler
Piper Sandler
Buy
Reiterates
$48$60
BuyReiterates$48$60+333.84%May 11, 2026
Guggenheim
Guggenheim
Buy
Maintains
$50
BuyMaintains$50+261.53%May 6, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.